These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9310014)

  • 1. Early bactericidal activity of isoniazid in pulmonary tuberculosis. Optimization of methodology. The DATRI 008 Study Group.
    Hafner R; Cohn JA; Wright DJ; Dunlap NE; Egorin MJ; Enama ME; Muth K; Peloquin CA; Mor N; Heifets LB
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):918-23. PubMed ID: 9310014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis.
    Donald PR; Sirgel FA; Botha FJ; Seifart HI; Parkin DP; Vandenplas ML; Van de Wal BW; Maritz JS; Mitchison DA
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):895-900. PubMed ID: 9310010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
    S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis.
    Sirgel FA; Botha FJ; Parkin DP; Van de Wal BW; Schall R; Donald PR; Mitchison DA
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):901-5. PubMed ID: 9310011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis.
    Gillespie SH; Gosling RD; Uiso L; Sam NE; Kanduma EG; McHugh TD
    J Antimicrob Chemother; 2005 Dec; 56(6):1169-71. PubMed ID: 16223939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis.
    Furin JJ; Du Bois J; van Brakel E; Chheng P; Venter A; Peloquin CA; Alsultan A; Thiel BA; Debanne SM; Boom WH; Diacon AH; Johnson JL
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6591-6599. PubMed ID: 27550361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.
    Gosling RD; Uiso LO; Sam NE; Bongard E; Kanduma EG; Nyindo M; Morris RW; Gillespie SH
    Am J Respir Crit Care Med; 2003 Dec; 168(11):1342-5. PubMed ID: 12917230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
    Chan SL; Yew WW; Ma WK; Girling DJ; Aber VR; Felmingham D; Allen BW; Mitchison DA
    Tuber Lung Dis; 1992 Feb; 73(1):33-8. PubMed ID: 1326348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid.
    Donald PR; Sirgel FA; Venter A; Parkin DP; Seifart HI; van de Wal BW; Werely C; van Helden PD; Maritz JS
    Clin Infect Dis; 2004 Nov; 39(10):1425-30. PubMed ID: 15546075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.
    Johnson JL; Hadad DJ; Boom WH; Daley CL; Peloquin CA; Eisenach KD; Jankus DD; Debanne SM; Charlebois ED; Maciel E; Palaci M; Dietze R
    Int J Tuberc Lung Dis; 2006 Jun; 10(6):605-12. PubMed ID: 16776446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time Trends in Sputum Mycobacterial Load and Two-Day Bactericidal Activity of Isoniazid-Containing Antituberculosis Therapies.
    De Jager V; van der Merwe L; Venter A; Donald PR; Diacon AH
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients.
    Diacon AH; Dawson R; Hanekom M; Narunsky K; Venter A; Hittel N; Geiter LJ; Wells CD; Paccaly AJ; Donald PR
    Int J Tuberc Lung Dis; 2011 Jul; 15(7):949-54. PubMed ID: 21682970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The early bactericidal activity of amikacin in pulmonary tuberculosis.
    Donald PR; Sirgel FA; Venter A; Smit E; Parkin DP; Van de Wal BW; Mitchison DA
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):533-8. PubMed ID: 11409580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment.
    Bark CM; Gitta P; Ogwang S; Nsereko M; Thiel BA; Boom WH; Eisenach KD; Joloba ML; Johnson JL
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1448-51. PubMed ID: 24125449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
    Dorman SE; Johnson JL; Goldberg S; Muzanye G; Padayatchi N; Bozeman L; Heilig CM; Bernardo J; Choudhri S; Grosset JH; Guy E; Guyadeen P; Leus MC; Maltas G; Menzies D; Nuermberger EL; Villarino M; Vernon A; Chaisson RE;
    Am J Respir Crit Care Med; 2009 Aug; 180(3):273-80. PubMed ID: 19406981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide in pulmonary tuberculosis patients.
    Paramasivan CN; Herbert D; Umapathy KC; Rahman F; Krishnamurthy PV; Prabhakar R
    Indian J Med Res; 1994 Jul; 100():1-4. PubMed ID: 7927544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis.
    Joloba ML; Johnson JL; Namale A; Morrissey A; Assegghai AE; Mugerwa RD; Ellner JJ; Eisenach KD
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):528-36. PubMed ID: 10864183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.